Cancer is a genomic disease (24), and gene expression at the mRNA level of markers involved in carcinogenesis, such as E-cadherin, needs to be evaluated in OSCC in the context of clinical characteristics associated with the disease. This evidence concerns the gene CDH1 and cancer.